Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses

Molecular Pharmacology

Volumn 70, Issue 5, 2006, Pages 1742-1749

  Li, Shuang ^a   Lee, Michael L ^a   Bruchas, Michael R ^a   Chan, Guy C ^a   Storm, Daniel R ^a   Chavkin, Charles ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALMODULIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MORPHINE; NALOXONE;

ANALGESIA; ANTINOCICEPTION; ARTICLE; GENE DELETION; KNOCKOUT MOUSE; LOCOMOTION; LONG TERM EXPOSURE; MALE; MORPHINE TOLERANCE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ADENYLATE CYCLASE; ANIMALS; BEHAVIOR, ANIMAL; CALMODULIN; CONDITIONING, CLASSICAL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE DELETION; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; MOTOR ACTIVITY; PAIN MEASUREMENT; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; VENTRAL TEGMENTAL AREA;

EID: 33751164658     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.025783     Document Type: Article

References (45)

1. Avidor-Reiss T, Bayewitch M, Levy R, Matus-Leibovitch N, Nevo I, and Vogel Z (1995) Adenylylcyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J Biol Chem 270: 29732-29738.
2. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, and Vogel Z (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβγ. J Biol Chem 271:21309-21315.
3. Bardo MT and Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 53:31-43.
4. 2+- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87:1203-1214.
5. Bohn LM, Lefkowitz RJ, and Caron MG (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in βarrestin-2 knock-out mice. J Neurosci 22:10494-10500.
6. Bonci A and Williams JT (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16:631-639.
7. Bonci A and Williams JT (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796-803.
8. Borgland SL (2001) Acute opioid receptor desensitization and tolerance: is there a link? Clin Exp Pharmacol Physiol 28:147-154.
9. Chao J and Nestler EJ (2004) Molecular neurobiology of drug addiction. Annu Rev Med 55:113-132.
10. Franklin BJK and Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
11. Harrison LM, Kastin AJ, and Zadina JE (1998) Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19:1603-1630.
12. Jolas T, Nestler EJ, and Aghajanian GK (2000) Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway. Neuroscience 95:433-443.
13. Kieffer BL and Evans CJ (2002) Opioid tolerance-in search of the holy grail. Cell 108:587-590.
14. Kim KS, Lee KW, Lee KW, Im JY, Yoo JY, Kim SW, Lee JK, Nestler EJ, and Han PL (2006) Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action. Proc Natl Acad Sci USA 103:3908-3913.
15. Koob GF and LeMoal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science (Wash DC) 278:52-58.
16. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, and Nestler EJ (1997) CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17:7890-7901.
17. Langroudi RM, Khoshnoodi MA, Abadi NY, Fahadan PT, Ghahremani MH, and Dehpour AR (2005) Effect of cyclosporin A on morphine-induced place conditioning in mice: involvement of nitric oxide. Eur J Pharmacol 507:107-115.
18. Licata SC and Pierce RC (2003) The roles of calcium/calmodulin-dependent and Ras/mitogen-activated protein kinases in the development of psychostimulant-induced behavioral sensitization. J Neurochem 85:14-22.
19. Liu JG and Anand KJ (2001) Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38:1-19.
20. McLaughlin JP, Marton-Popovici M, and Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674-5683.
21. Muglia LM, Schaefer ML, Vogt SK, Gurtner G, Imamura A, and Muglia LJ (1999) The 5′-flanking region of the mouse adenylyl cyclase type VIII gene imparts tissue-specific expression in transgenic mice. J Neurosci 19:2051-2058.
22. Nemmani KV, Lalonde J, and Mogil JS (2005) Region-specific changes of calcium/calmodulin-dependent protein kinase IV in the mouse brain following chronic morphine treatment. Neuroreport 16:879-882.
23. Nestler EJ (2004a) Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25:210-218.
24. Nestler EJ (2004b) Molecular mechanisms of drug addiction. Neuropharmacology 47 (Suppl 1):24-32.
25. Nestler EJ and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science (Wash DC) 278:58-63.
26. Olson VG, Zabetian CP, Bolanos CA, Edwards S, Barrot M, Eisch AJ, Hughes T, Self DW, Neve RL, and Nestler EJ (2005) Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J Neurosci 25:5553-5562.
27. Rezayof A, Zatali H, Haeri-Rohani A, and Zarrindast MR (2006) Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward. Behav Brain Res 166:281-290.
28. Schaefer ML, Wong ST, Wozniak DF, Muglia LM, Liauw JA, Zhuo M, Nardi A, Hartman RE, Vogt SK, Luedke CE, et al. (2000) Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice. J Neurosci 20:4809-4820.
29. Soderling TR (2000) CaM-kinases: modulators of synaptic plasticity. Curr Opin Neurobiol 10:375-380.
30. 2+/calmodulin-dependent protein kinase II. J Pharmacol Exp Ther 317:901-909.
31. Terman GW, Jin W, Cheong YP, Lowe J, Caron MG, Lefkowitz RJ, and Chavkin C (2004) G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br J Pharmacol 141:55-64.
32. Thomas GM and Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5:173-183.
33. Tolliver BK, Ho LB, Reid MS, and Berger SP (1996) Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants. J Pharmacol Exp Ther 278:411-420.
34. Valverde O, Mantamadiotis T, Torrecilla M, Ugedo L, Pineda J, Bleckmann S, Gass P, Kretz O, Mitchell JM, Schutz G, et al. (2004) Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology 29:1122-1133.
35. Walters CL and Blendy JA (2001) Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J Neurosci 21:9438-9444.
36. Walters CL, Kuo YC, and Blendy JA (2003) Differential distribution of CREB in the mesolimbic dopamine reward pathway. J Neurochem 87:1237-1244.
37. Wang H, Ferguson GD, Pineda VV, Cundiff PE, and Storm DR (2004) Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP. Nat Neurosci 7:635-642.
38. 2+ stimulation of cAMP accumulation in mouse parotid acini. J Biol Chem 275:14691-14699.
39. Wei F, Qiu CS, Kim SJ, Muglia L, Maas JW, Pineda VV, Xu HM, Chen ZF, Storm DR, Muglia LJ, et al. (2002) Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases. Neuron 36:713-726.
40. Widnell KL, Russell DS, and Nestler EJ (1994) Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci USA 91:10947-10951.
41. Williams JT, Christie MJ, and Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
42. Wong ST, Athos J, Figueroa XA, Pineda VV, Schaefer ML, Chavkin CC, Muglia LJ, and Storm DR (1999) Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron 23:787-798.
43. Wu ZL, Thomas SA, Villacres EC, Xia Z, Simmons ML, Chavkin C, Palmiter RD, and Storm DR (1995) Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci USA 92:220-224.
44. Xia Z, Choi EJ, Wang F, Blazynski C, and Storm DR (1993) Type I calmodulin-sensitive adenylyl cyclase is neural specific. J Neurochem 60:305-311.
45. Xia Z and Storm DR (1997) Calmodulin-regulated adenylyl cyclases and neuromodulation. Curr Opin Neurobiol 7:391-396.